[Vulvovaginal mycoses-stort-term treatment with Econazole (author's transl)].
The short-term treatment (3 days) of mycologically demonstrated vulvovaginal candidiasis with econazole vaginal suppositories 150 mg was tested in a population of 194 women. Substancial prerequisites for thorough and complete performance of the therapy are high cure rates (93,3%), prompt therapeutic results, minor burden for the patient and good tolerability. In view of the vital danger for the newborn provoked by candidiasis morbidity, this short-term therapy is also indicated for prenatal prophylaxis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D004464:Econazole / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors
D007093:Imidazoles; D004464:Econazole
Vulvovaginale Mykosen-Kurztherapie (3 Tage) mit Econazol